Skip to content
easybpt
Browse topics

Pharmacology

Methotrexate pharmacology and toxicity

How low-dose weekly methotrexate works (polyglutamates and adenosine), its saturable absorption and renal clearance, why trimethoprim and daily dosing errors cause pancytopenia, folate supplementation and folinic acid rescue, and the monitoring and pregnancy rules examiners test.

Tier 1Medical sciences concept

Written with AI assistance and fact-checked against the sources below. For exam study, not clinical decisions. How notes are made

3 questions9 flashcards

At a glance

  • Low-dose methotrexate (7.5 to 25 mg once weekly) is the anchor csDMARD for RA and is used in PsA, psoriasis, vasculitis and as a steroid-sparing agent. Onset takes 6 to 12 weeks.
  • At these doses the anti-inflammatory effect comes mainly from adenosine release, not DHFR block. High-dose oncology regimens (grams per m²) work by DHFR inhibition and need folinic acid rescue.
  • It is renally cleared. Falling GFR, NSAIDs, trimethoprim and dehydration all push levels up.

Loading the rest of the note…

Finished reading?

Test yourself on it:3 questions9 flashcards

Sources

Last updated
14 November 2026
What changed
  • 14 November 2026 Personal emails, About story and Australian-style copy

Send feedback

Type of feedback

The page you're on and your device type are attached automatically.